Watchlist Price Alert

Magenta Therapeutics Inc. (MGTA)

NASDAQ: MGTA · Real-Time Price · USD

0.70

-0.06 (-7.69%)

At close: Sep 11, 2023, 8:00 PM

Magenta Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-76.46M	-71.14M	-74.94M	-76.77M	-57.52M	-35.49M	-9.43M
Depreciation & Amortization	1.93M	2.02M	1.98M	1.84M	875K	376K	6K
Stock-Based Compensation	7.02M	10.31M	9.94M	10M	10.7M	2.26M	662K
Other Working Capital	-1.9M	-806K	-2.13M	8.69M	1.67M	2.44M	590K
Other Non-Cash Items	3.13M	803K	180K	-1.01M	-190K	9.28M	638K
Deferred Income Tax	n/a	n/a	n/a	n/a	67K	n/a	n/a
Change in Working Capital	-2.7M	-1.53M	-1.19M	8.83M	4.17M	1.32M	1.6M
Operating Cash Flow	-67.09M	-59.53M	-64.02M	-57.1M	-41.89M	-22.26M	-6.53M
Capital Expenditures	-314K	-1.26M	-400K	-3.06M	-7.67M	-2.2M	-139K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-69.5M	-45.31M	-95.73M	-144.37M	-84.04M	n/a	n/a
Sales Maturities Of Investments	60M	90M	85.5M	148.96M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	12K	-135K	n/a
Investing Cash Flow	-9.81M	43.43M	-10.63M	1.53M	-91.7M	-2.33M	-139K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	115K	141K	104K	n/a	-88K	-213K	-107K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.88M	89.6M	67.74M	62.3M	142.15M	71.49M	10.71M
Financial Cash Flow	2.88M	89.6M	67.74M	62.3M	142.15M	71.49M	10.71M
Net Cash Flow	-74.02M	73.5M	-6.92M	6.73M	8.56M	46.89M	4.04M
Free Cash Flow	-67.4M	-60.8M	-64.42M	-60.16M	-49.56M	-24.46M	-6.67M